/SPHS
Sophiris Bio, Inc.
SPHS • OTCSPHS • OTC • Healthcare
$0.00+0.00%+0.00
$0.00+0.00%(+0.00)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
70Bullish
Risk
100Low Risk
Momentum
0Negative
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
No margin data
Valuation Snapshot
P/E Ratio
-3.3
Price vs earnings
EV/EBITDA
-3.4
Enterprise value
FCF Yield
-53.9%
Cash generation
Earnings Yield
-29.9%
Inverse of P/E
Capital Efficiency
-170
GoAI Quality ScorePoor
ROEReturn on Equity
-430.1%Weak
ROAReturn on Assets
-56.5%Weak
ROICReturn on Invested Capital
-60.1%Weak
Financial Health
Current RatioHealthy
2.65
Short-term solvency (>1.5)
Net Debt / EBITDAManageable
0.65x
Debt repayment capacity (<3x)
Income QualityStrong
1.99
Cash backs earnings (>1)
Revenue & Profitability
No revenue data
Income Statement
| Metric | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -$6.09M | -$8.42M | -$10.87M | -$13.51M | -$29.99M |
| Net Income | -$7.46M | -$8.84M | -$11.46M | -$14.89M | -$31.44M |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | -$0.25 | -$0.29 | -$0.50 | -$0.88 | -$1.90 |
Rating Distribution
Strong Buy
0
0%
Buy
3
100%
Hold
0
0%
Sell
0
0%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Rodman & Renshaw● Maintain
Buy
2017-03-13Roth Capital● Maintain
Buy
2016-09-15PiperJaffray● Maintain
Overweight
2016-08-30Earnings History & Surprises
BEAT RATE
0%
Last 0 quarters
AVG SURPRISE
+0%
EPS vs Estimate
BEATS / MISSES
0/0
Last 0 quarters
LATEST EPS
$-0.03
Q3 '19
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q3 '19
No data
Q2 '19
No data
Q1 '19
No data
Q4 '18
No data
Q3 '18
No data
Q2 '18
No data
Q1 '18
No data
Q4 '17
No data
Q3 '17
No data
Q2 '17
No data
Q1 '17
No data
Q4 '16
No data
No investor questions available.
Latest News
No news available